Search Results 1681-1690 of 18377 for Lupus
Peter C. Lucas, M.D., Ph.D., is a pathologist and scientist at Mayo Clinic who studies oncoimmune signaling pathways in lymphoma, breast cancer and other ...
This randomized phase III trial studies cytarabine and daunorubicin hydrochloride or idarubicin and cytarabine with or without vorinostat to see how well they ...
Education · 2008. Fellow - Diagnostic NeuroradiologyBarrow Neurological Institute, St. · 2006. Resident - Diagnostic RadiologyUniversity of Texas, Southwestern ...
Learn about this cancer that forms in the blood and bone marrow. Treatments include medicines and bone marrow transplant, also called stem cell transplant.
Dr. Cerhan's Lymphoma Epidemiology Lab at Mayo Clinic coordinates the LEO cohort study of unmet health needs for patients with non-Hodgkin lymphoma.
Department of Medicine (DOM) and the Internal Medicine Residency Program Highest Rated Educators within Resident Education - Emergency MedicineDepartment of ...
The Human and Integrative Physiology and Clinical Pharmacology Lab of Michael J. Joyner, M.D., at Mayo Clinic studies response to physical and mental stress ...
2006. Fellow - Clinical Neurophysiology; ElectromyographyMayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 2005. ResidentNeurology, ...
Patients with Acute Myeloid Leukemia (AML) in complete remission will receive eltrombopag while undergoing consolidation chemotherapy with high-dose cytarabine.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!